Arch Life Sciences Limited - Company Profile

Q: Who are the current directors of Arch Life Sciences Limited?

The current directors of Arch Life Sciences Limited are Ajit Annu Kamath, Rajendra Padmanabhan Kaimal, Chetan Ajitkumar Shah.

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2003.

2003 Hyderabad, Telangana, India Active

Last Updated: December 30, 2025

Access Report

About Arch Life Sciences Limited

Arch Life Sciences Limited, a active public limited company, was established on 15 December 2003 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239TG2003PLC042232. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹3.90 Cr.

Formerly known as Sibra Pharmaceuticals Limited. It upholds a compliant status. Its leadership includes Ajit Annu Kamath (Director), Rajendra Padmanabhan Kaimal (Director), Chetan Ajitkumar Shah (Director). Past directors included Sivarama Prasad Manne, Valiveti Brahmaji, Manoor Sayed Husain Sayed. It holds ₹100.00 Cr open charges and ₹7.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No. 8-2-684/J/8/A, Bhavani Nagar, Road No.12 Banjara Hills, Hyderabad, Hyderabad, Telangana, 500034.

Company Details

CIN/LLPIN
U24239TG2003PLC042232
Registration Number
042232
Incorporation Date
15 December 2003
Authorized Capital
₹25.00 Cr
Paid-Up Capital
₹3.90 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 25.00 Cr as on 30-12-2025
Paid Up Capital ₹ 3.90 Cr as on 30-12-2025
Company Age 22 Year, 1 Month
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 100.00 Cr as on 30-12-2025
Satisfied Charges ₹ 7.75 Cr as on 30-12-2025
Revenue Growth **** -90.93% (FY 2023)
Profit Growth **** -118.05% (FY 2023)
Ebitda **** -24.64% (FY 2023)
Net Worth -0.03% (FY 2023)
Total Assets -0.05% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Arch Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Arch Life Sciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ajit Annu Kamath	Director	02 Apr 2007	Current
Rajendra Padmanabhan Kaimal	Director	02 Apr 2007	Current
Chetan Ajitkumar Shah	Director	28 Oct 2017	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	04 Dec 2008	Past
Pramod Abcsdd	Director	13 Feb 2008	Past
Pramod Abcsdd	Additional Director	29 Mar 2019	Past
Pramod Abcsdd	Director	15 Jul 2014	Past
Pramod Abcsdd	Director	15 Mar 2008	Past
Pramod Abcsdd	Additional Director	29 Mar 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arch Life Sciences.

Arch Life Sciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 90.93% decrease. The company also saw a substantial fall in profitability, with a 118.05% decrease in profit. The company's net worth dipped by a decrease of 0.03%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-90.93%

*******

Revenue from Operations

*******

Total Assets

*******

-0.05%

*******

Profit or Loss

*******

-118.05%

*******

Net Worth

*******

-0.03%

*******

EBITDA

*******

-24.64%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arch Life Sciences?

In 2023, Arch Life Sciences had a promoter holding of 58.46% and a public holding of 41.54%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,000,000,000.00

Satisfied Charges

₹77,500,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 57.00 Cr
State Bank Of Patiala : 27.75 Cr
Indusind Bank Ltd. : 15.25 Cr

Latest Charge Details

Date	Lender	Amount	Status
11 Nov 2008	State Bank Of India	₹57.00 Cr	Open
01 Mar 2008	Indusind Bank Ltd.	₹15.25 Cr	Open
01 Mar 2008	State Bank Of Patiala	₹27.75 Cr	Open
29 Sep 2004	Uco Bank	₹7.75 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Arch Life Sciences?

Unlock and access historical data on people associated with Arch Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Arch Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arch Life Sciences

Recent Activity within the Organization

Annual General Meeting

Arch Life Sciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

Progress on Arch Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
31 Mar 2024
Director Appointment

Progress on Chetan Ajitkumar Shah was appointed as a Director was appointed as a Director on 28 Oct 2017 & has been associated with this company since 8 years 3 months . was documented.
28 Oct 2017
Charges

A charge with State Bank Of India of Rs. 57.00 Cr registered on 11 Nov 2008 with Charge ID 10136147 was modified on 30 May 2009. was recorded as a recent event.
30 May 2009
Charges

Progress on A charge with State Bank Of India amounted to Rs. 57.00 Cr with Charge ID 10136147 was registered on 11 Nov 2008. was documented.
11 Nov 2008
Charges

The activity A charge with Indusind Bank Ltd. amounted to Rs. 15.25 Cr with Charge ID 10109603 was registered on 01 Mar 2008. was completed.
01 Mar 2008

Explore recent activity and updates - View Recent Activity